Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-000965
Filing Date
2018-03-27
Accepted
2018-03-27 06:06:12
Documents
73
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1821382.htm 20-F 2113220
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 320204
3 EXHIBIT 8.1 exhibit_8-1.htm EX-8.1 3442
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 9974
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 9966
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5741
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 3456
14 image00001.jpg GRAPHIC 2790
15 image00003.jpg GRAPHIC 36381
  Complete submission text file 0001178913-18-000965.txt   6542687

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cgen-20171231.xml EX-101.INS 1032426
9 XBRL TAXONOMY EXTENSION SCHEMA cgen-20171231.xsd EX-101.SCH 50870
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cgen-20171231_cal.xml EX-101.CAL 68661
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cgen-20171231_def.xml EX-101.DEF 177897
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgen-20171231_lab.xml EX-101.LAB 419840
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgen-20171231_pre.xml EX-101.PRE 294934
Mailing Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849
Business Address 26 HAROKMIM STREET BUILDING D HOLON L3 5885849 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30902 | Film No.: 18714043
SIC: 2836 Biological Products, (No Diagnostic Substances)